DarioHealth Corp.
DRIO
$0.6301
$0.00811.30%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 111.00% | 1.67% | -18.50% | -46.89% | -46.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 111.00% | 1.67% | -18.50% | -46.89% | -46.74% |
| Cost of Revenue | 22.20% | -24.06% | -23.22% | -16.56% | -51.30% |
| Gross Profit | 204.25% | 25.92% | -15.37% | -68.75% | -40.93% |
| SG&A Expenses | -0.29% | 11.64% | 31.06% | 44.01% | -9.33% |
| Depreciation & Amortization | 21.52% | 12.71% | 7.59% | -9.87% | 0.09% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.04% | 11.27% | 21.25% | 11.91% | -9.98% |
| Operating Income | 22.62% | -15.49% | -43.89% | -56.35% | -6.68% |
| Income Before Tax | 21.54% | 17.94% | 28.51% | -12.74% | -0.64% |
| Income Tax Expenses | -- | -- | -- | 2,033.33% | -- |
| Earnings from Continuing Operations | 21.62% | 17.94% | 44.05% | -13.22% | -0.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.62% | 17.94% | 44.05% | -13.22% | -0.64% |
| EBIT | 22.62% | -15.49% | -43.89% | -56.35% | -6.68% |
| EBITDA | 27.85% | -12.12% | -47.59% | -64.52% | -7.22% |
| EPS Basic | 50.20% | 85.41% | 55.46% | 21.75% | 22.67% |
| Normalized Basic EPS | 44.05% | 41.92% | 42.84% | -0.16% | 19.77% |
| EPS Diluted | 49.25% | 85.41% | 55.46% | 22.17% | 23.03% |
| Normalized Diluted EPS | 44.05% | 41.92% | 42.84% | -0.16% | 19.77% |
| Average Basic Shares Outstanding | 40.26% | 41.31% | 24.93% | 11.54% | 25.43% |
| Average Diluted Shares Outstanding | 40.26% | 41.31% | 24.93% | 11.54% | 25.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
